(Natural News)—If you never did before, now is the time to raise serious concerns about thimerosal (a mercury-containing preservative) in vaccines. The ACIP (Advisory Committee on Immunization Practices) is downplaying risks despite calls from multiple agencies (CDC, FDA, NIH, etc.) to remove it.
Thimerosal Safety Controversy: Critics argue that official safety assurances (CDC, ACIP) ignore documented risks of thimerosal, a mercury-based preservative linked to neurotoxicity, developmental harm and other serious health issues — especially in infants and pregnant women.
- Policy Shift or Stagnation: The upcoming ACIP vote under new leadership (appointed by RFK Jr.) could either address long-standing concerns by phasing out thimerosal or maintain current policies, deepening public distrust in vaccine guidelines.
- Lack of Transparency: Accusations persist that federal agencies use deceptive labeling (e.g., listing thimerosal instead of “mercury”) and withhold safety data, while state mandates rely on incomplete ACIP recommendations, denying exemptions for vulnerable groups.
- Call for Independent Oversight: The article urges reliance on alternative media (e.g., Vaccines.news, NaturalNews.com) for truth about vaccine ingredients, citing investigations that challenge CDC claims and advocate for thimerosal’s removal.
The upcoming ACIP vote could either address these concerns or maintain current policies, with new leadership potentially influencing the decision. The CDC has not clarified its stance, fueling skepticism.
- Thimerosal Controversy: Claims official safety assurances ignore risks.
- Policy Divide: Upcoming ACIP vote may shift or entrench current vaccine policies.
- Transparency Criticisms: Accusations of deceptive labeling and lack of CDC accountability.
- Call to Action: Encourages reliance on alternative media (Vaccines.news) for “truth” about vaccine ingredients.
CDC vaccine panel to vote on thimerosal in flu shots amid controversy over mercury safety
The CDC’s Advisory Committee on Immunization Practices (ACIP) will vote next week on whether to continue recommending flu vaccines containing thimerosal, a mercury-based preservative, amid renewed scrutiny over its safety. The June 25-26 meeting in Atlanta marks the first since HHS Secretary Robert F. Kennedy Jr. replaced all 17 former ACIP members in a bid to restore public trust in vaccine policy. The panel will also decide on RSV vaccines for pregnant women and young children, despite clinical trial data showing an 11.71% rate of serious adverse events.
Thimerosal, used in multi-dose flu vaccine vials, has been a flashpoint in vaccine debates for decades. Though the CDC maintains it poses no harm, critics cite a 1999 internal meeting where officials acknowledged risks to infant brain development. In 2001, thimerosal was removed from childhood vaccines, yet it remains in some flu shots.
Dr. Meryl Nass, a longtime ACIP observer, stated, “There is no need for thimerosal, a known neurotoxin, as it is not used in single-dose vials. Its use should be ended.” Meanwhile, journalist Sharyl Attkisson’s investigation challenged federal claims that thimerosal is safe, fueling calls for transparency.
The committee’s focus on thimerosal has drawn polarized responses. Brian Hooker of Children’s Health Defense criticized the CDC’s “biased viewpoint,” while Medpage editor Dr. Jeremy Faust called the vote a revival of “anti-vaccine conspiracy theories.” Others, like researcher James Lyons-Weiler, see potential progress: “If safety data are rigorously evaluated, this could mark a turning point.”
ACIP’s recommendations often shape state vaccine mandates, yet its guidelines lack exhaustive safety data. Attorney Sujata Gibson noted that states like New York and California deny medical exemptions for conditions not listed in ACIP’s framework, risking harm to vulnerable children.
Next week’s vote could signal a shift in U.S. vaccine policy — or deepen existing divides. With thimerosal’s safety back under scrutiny and new leadership at ACIP, the outcome may hinge on whether the committee prioritizes public trust or maintains the status quo. The CDC did not respond to requests for comment on whether it will clarify its guidelines’ limitations.
Bookmark Vaccines.news to your favorite independent websites for updates on toxic injections like the multi-dose flu jab and DTaP that STILL to this day contain mercury, listed as thimerosal in order to trick the populace.
Sources for this article include:
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.